Abstract:Background: Beyond magnetic resonance imaging (MRI), which has been widely used clinically, molecular MRI (mMRI) can further provide qualitative and quantitative information at the cellular and molecular levels. However, the diagnostic accuracy may not be satisfactory via single-contrast mMRI due to some interferences in vivo. T-1/T-2 dual-contrast MRI using the same contrast agent (CA) could significantly improve the detection accuracy. Therefore, in this study, we fabricated poly(ethylene glycol) (PEG)-coated, manganese-doped iron oxide nanocomposites (Mn-IONPs@PEG) as T-1/T-2 dual-contrast CA, and evaluated its feasibility of T-1/T-2 dual-contrast MRI in vitro and in vivo. Methods: Mn-IONPs were prepared by the thermal decomposition of iron-eruciate and manganese-oleate complexes and were coated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy[polyethylene glycol]-2000) (DSPE-PEG 2000). The physicochemical properties and cytotoxicity of the Mn-IONPs were fully characterized, followed by MRI in vitro and in vivo. Results: Ultrasmall 3 nm-sized nanoparticles were successfully prepared and were identified using transmission electron microscopy (TEM), high-resolution TEM, and X-ray diffraction. After coating with DSPE-PEG, the Mn-IONPs@PEG displayed excellent hydrophilicity and good biocompatibility. Due to the manganese-doping and PEG coating, the Mn-IONPs@PEG showed good relaxivity in vitro. Especially, the Mn-IONPs@PEG coated with DSPE-PEG following a mass ratio to Mn-IONPs of 1:20 showed harmonious longitudinal relaxivity (r(1) = 7.1 mM(-1) s(-1)) and transversal relaxivity (r(2) = 120.9 mM(-1) s(-1)), making it a better candidate for T-1/T-2 dual-contrast mMRI. After administrated via a caudal vein, the Mn-IONPs@PEG can induce significant enhancement in both T-1-weighted and T-2-weighted MR images and the time at 10 mins after injection was regarded as a suitable time for imaging because both the T-1 and T-2 enhancement were optimum at that time. Conclusion: The obtained Mn-IONPs@PEG exhibited good r(1) and r(2) and was a reasonable candidate for T-1/T-2 dual-contrast mMRI.

Multinuclear Mn(II) United-Dota Complexes with Enhanced Inertness and High MRI Contrast Ability

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes from DTPA-Bisamide Derivative As Potential MRI Contrast Agents

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Synthesis And Evaluation Of A High Relaxivity Manganese(Ii)-Based Mri Contrast Agent

Multivalent manganese complex decorated amphiphilic dextran micelles as sensitive MRI probes

Carbonized Paramagnetic Complexes of Mn (II) As Contrast Agents for Precise Magnetic Resonance Imaging of Sub-Millimeter-sized Orthotopic Tumors

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Manganese-Loaded Dual-Mesoporous Silica Spheres for Efficient T1- and T2-Weighted Dual Mode Magnetic Resonance Imaging

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Facile Synthesis of Rigid Binuclear Manganese Complexes for Magnetic Resonance Angiography and SLC39A14-Mediated Hepatic Imaging.

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents

A self-assembly heterotrinuclear gadolinium(III)-iron(II) complex as a MRI contrast agent

Mn(ii) Chelate-Coated Superparamagnetic Iron Oxide Nanocrystals As High-Efficiency Magnetic Resonance Imaging Contrast Agents

Manganese-based contrast agents for MRI

Evaluation of Dendritic Gadolinium Complexes as MRI Contrast Agents

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Synthesis and T1-relaxation enhancement of neutral oligomeric manganese(II) complexes as MRI contrast agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.